肝星状细胞
颠倒
核酸
肝纤维化
超分子化学
化学
阻塞(统计)
生物物理学
纳米技术
细胞生物学
纤维化
材料科学
生物化学
生物
医学
结晶学
病理
计算机科学
内分泌学
晶体结构
复合材料
计算机网络
作者
Yao Xu,Yu Fan,Zinan Zhao,Wei Hu,Yuyan Qian,Yong Hu
出处
期刊:ACS Nano
[American Chemical Society]
日期:2025-04-14
卷期号:19 (16): 15444-15456
被引量:9
标识
DOI:10.1021/acsnano.4c15562
摘要
Inhibition of hepatic stellate cell (HSC) activation and reversal of its activation state represent two distinct yet complementary strategies in antifibrotic therapy. While synergy of those two strategies is anticipated to improve the therapeutic outcomes, synergism through nanomedicine remains elusive. Herein, we report a circular spherical nucleic acid (cSNA) with a supramolecular core comprising collagenase I and ML-290 and a surface attached with circular PDGF-BB aptamer instead of the stereotypical linear counterpart. Unlike conventional inert SNA, this cSNA core dissociates in response to elevated ROS levels in the fibrotic liver so that collagenase I is released to disrupt the collagen barrier to promote the penetration of ensuing nanoparticles. Of significant importance is that the PDGF-BB aptamer after circularization exhibits enhanced nuclease resistance and improved molecular recognition, thereby demonstrating superior capability in blocking HSC activation mediated by PDGF-BB/PDGFR-β signaling. Meanwhile, relaxin family peptide receptor 1 (RXFP1) agonist ML-290 initially transforms pro-fibrogenic macrophages into pro-resolution macrophages by activating RXFP1 signaling, facilitating the secretion of pro-resolution factors for the reversal of the activated state of HSCs. This work thus presents a proof-of-concept demonstration of a supramolecular SNA that undergoes structural and functional refinements, enabling concurrent upstream etiological blockade and downstream pathological restoration in liver fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI